Advertisement
  • May 21: The Week in Cancer News

    The U.S. Preventive Services Task Force lowers its recommended age to begin colorectal cancer screening to 45, and a major multiple myeloma study begins in Iceland.

    by Bradley Jones

  • Rethinking Access to Disability Benefits

    Advances in screening and treatment mean there are more cancer survivors than ever, but survivors who struggle to work can face difficulty getting disability payments.

    by Jen Tota McGivney

  • Should All Kids With Cancer Get Genetic Testing?

    Testing children with cancer for hereditary mutations could impact their treatment and provide information relevant to other family members.

    by Marcus A. Banks

  • Understanding How Radiation Causes Cancer

    Researchers are investigating who is at greatest risk for radiation-induced cancers.

    by Kate Yandell

  • How Long Do Immunotherapy Side Effects Last?

    For people with melanoma who receive immune checkpoint inhibitors after surgery, side effects can remain even after treatment has been completed. These chronic side effects are most often mild.

    by Anna Goshua

  • Chemobrain: It’s Not Your Imagination

    Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021.

    by Marci A. Landsmann

  • Searching the Blood for Signs of Altered Immunity

    The immune systems of people with blood cancer respond differently to infection with the coronavirus than the immune systems of people without cancer or with solid tumors.

    by Kate Yandell

  • March 26: The Week in Cancer News

    Underrepresentation of members of minority groups in public genomic databases could lead to misleading test results, and a study provides new insight into how melanoma metastasizes.

    by Bradley Jones

  • Forward Look

    A Strategy to Watch

    Some rectal cancer patients may safely avoid life-altering surgery.

    by Kristine Conner

  • Healthy Habits

    Daily Dose

    Aspirin can be taken daily to reduce the risk of colorectal cancer, but it's not recommended for everyone.

    by Bradley Jones